Sky News Network
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • National
  • Culture
  • Science & Technology
  • Opinion
  • Sports
No Result
View All Result
Sky News Network
No Result
View All Result
Home Science & Technology

Aspirin linked with increased risk of heart failure, new study

skynewsbyskynews
November 23, 2021
in Science & Technology, Uncategorized
0
Aspirin linked with increased risk of heart failure, new study
0
SHARES
193
VIEWS
Share on FacebookShare on TwitterWhatsapp

Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition, according to a study published in ESC Heart Failure, a journal of the European Society of Cardiology (ESC) on November 22, 2021).

Predisposing factors included smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease.

Aspirin is commonly used for pain relief and fever reducer in adults.

“This is the first study to report that among individuals with a least one risk factor for heart failure, those taking aspirin were more likely to subsequently develop the condition than those not using the medication,” said study author Dr. Blerim Mujaj of the University of Freiburg, Germany.

The influence of aspirin on heart failure is controversial. This study aimed to evaluate its relationship with heart failure incidence in people with and without heart disease and assess whether using the drug is related to a new heart failure diagnosis in those at risk.

The analysis included 30,827 individuals at risk for developing heart failure who were enrolled from Western Europe and the US into the HOMAGE study.

“At risk” was defined as one or more of the following: smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease.

Participants were aged 40 years and above and free of heart failure at baseline. Aspirin use was recorded at enrolment and participants were classified as users or non-users. Participants were followed up for the first incidence of fatal or non-fatal heart failure requiring hospitalization.

The average age of participants was 67 years and 34% were women. At baseline, a total of 7,698 participants (25%) were taking aspirin. During the 5.3-year follow-up, 1,330 participants developed heart failure.

The investigators assessed the association between aspirin use and incident heart failure after adjusting for sex, age, body mass index, smoking, alcohol use, blood pressure, heart rate, blood cholesterol, creatinine, hypertension, diabetes, cardiovascular disease, and treatment with renin-angiotensin-aldosterone-system inhibitors, calcium channel blockers, diuretics, beta-blockers, and lipid-lowering drugs.

Taking aspirin was independently associated with a 26% raised risk of a new heart failure diagnosis.

To check the consistency of the results, the researchers repeated the analysis after matching aspirin users and non-users for heart failure risk factors. In this matched analysis, aspirin was associated with a 26% raised risk of a new heart failure diagnosis.

To check the results further, the analysis was repeated after excluding patients with a history of cardiovascular disease. In 22,690 participants (74%) free of cardiovascular disease, aspirin use was associated with a 27% increased risk of incident heart failure.

Dr. Mujaj said: “This was the first large study to investigate the relationship between aspirin use and incident heart failure in individuals with and without heart disease and at least one risk factor. Aspirin is commonly used – in our study one in four participants were taking the medication. In this population, aspirin use was associated with incident heart failure, independent of other risk factors.”

He concluded: “Large multinational randomized trials in adults at risk for heart failure are needed to verify these results. Until then, our observations suggest that aspirin should be prescribed with caution in those with heart failure or with risk factors for the condition.”

Source: Scitechdaily
Plugin Install : Subscribe Push Notification need OneSignal plugin to be installed.
skynews

skynews

Related Posts

New method can stop cyberattacks in less than a second
Science & Technology

New method can stop cyberattacks in less than a second

June 21, 2022
Uganda, Kenya tech startups to battle other African giants for continental awards
Science & Technology

Uganda, Kenya tech startups to battle other African giants for continental awards

May 10, 2022
New science shows you can become younger by 30 years
Science & Technology

New science shows you can become younger by 30 years

May 5, 2022

Popular Stories

  • How corruption has eaten up Uganda’s water corporation

    How corruption has eaten up Uganda’s water corporation

    0 shares
    Share 0 Tweet 0
  • Uganda’s water boss lined up for sacking as wife shames minister in party elections

    0 shares
    Share 0 Tweet 0
  • NWSC Board probes Silver Mugisha as Museveni unleashes intelligence on water ministry

    0 shares
    Share 0 Tweet 0
  • Assassinations: who is spilling blood in Uganda, and why?

    0 shares
    Share 0 Tweet 0
  • How Ugandan brokers sealed Museveni, Ruto deal throwing Kenyatta, Odinga into chaos

    0 shares
    Share 0 Tweet 0

Archives

About Us

We are the leading online news publication in Uganda with authentic and reliable news.

LEARN MORE »

Recent News

  • Prince Charles represents Queen at Commonwealth meeting in Rwanda June 22, 2022
  • New method can stop cyberattacks in less than a second June 21, 2022
  • We all have to work together in DRC, Museveni tells EAC colleagues June 21, 2022

Quick Links

  • About us
  • Advertise
  • Careers
  • Contact Us

Address

UJA House, Bombo Rd,

Keti Falawo Zone, Kawempe Division

Kampala – Uganda

© 2020 – Sky News Network

No Result
View All Result
  • Home
  • Politics
  • News
  • Business
  • National
  • Sports
  • Science & Technology
  • Agriculture & African Medicine
  • Travel
  • Opinion

© 2020 Sky News Uganda

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.